• Home
  • Sequential JAK inhibition enhances antitumor immunity after combined anti-PD-1 and anti-CTLA4.

Sequential JAK inhibition enhances antitumor immunity after combined anti-PD-1 and anti-CTLA4.

Author List
Arias-Badia M, Chen P, Lwin YM, Srinath A, Lyu A, Fan Z, Kwek SS, Luong DN, Setayesh A, Sakamoto M, Clark M, Lea A, Wolters RM, Goodearl A, Harding FA, Gorman JV, Ritacco W, Fong L
Publication
JCI insight
Publication ID (Profile URL)
https://researcherprofiles.org/profile/595333893
Publication Year
2025
PubMed ID
40014402
Publication Title
Arias-Badia M, Chen P, Lwin YM, Srinath A, Lyu A, Fan Z, Kwek SS, Luong DN, Setayesh A, Sakamoto M, Clark M, Lea A, Wolters RM, Goodearl A, Harding FA, Gorman JV, Ritacco W, Fong L. Sequential JAK inhibition enhances antitumor immunity after combined anti-PD-1 and anti-CTLA4. JCI Insight. 2025 Feb 27; 10(7).